These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12871458)

  • 1. Poor anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombosis.
    Tardy-Poncet B; Tardy B; Laporte S; Mismetti P; Amiral J; Piot M; Reynaud J; Campos L; Decousus H
    J Thromb Haemost; 2003 Mar; 1(3):507-10. PubMed ID: 12871458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study.
    Cao X; Su Y; Zhang W; Zhao H; Wen M; Lu S; Zhao Y; Chen Y; Liu L; Zang X; Wu J
    Clin Appl Thromb Hemost; 2021; 27():10760296211063877. PubMed ID: 34898295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased anticoagulant response to tissue factor pathway inhibitor in patients with venous thromboembolism and otherwise no evidence of hereditary or acquired thrombophilia.
    Bombeli T; Piccapietra B; Boersma J; Fehr J
    Thromb Haemost; 2004 Jan; 91(1):80-6. PubMed ID: 14691572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.
    Zakai NA; Lutsey PL; Folsom AR; Heckbert SR; Cushman M
    Thromb Haemost; 2010 Aug; 104(2):207-12. PubMed ID: 20431849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis.
    Ariëns RA; Alberio G; Moia M; Mannucci PM
    Thromb Haemost; 1999 Feb; 81(2):203-7. PubMed ID: 10063992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
    Dahm A; Van Hylckama Vlieg A; Bendz B; Rosendaal F; Bertina RM; Sandset PM
    Blood; 2003 Jun; 101(11):4387-92. PubMed ID: 12560220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
    Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
    Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.
    Dahm A; Rosendaal FR; Andersen TO; Sandset PM
    Br J Haematol; 2006 Feb; 132(3):333-8. PubMed ID: 16409298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.
    Dennis J; Truong V; Aïssi D; Medina-Rivera A; Blankenberg S; Germain M; Lemire M; Antounians L; Civelek M; Schnabel R; Wells P; Wilson MD; Morange PE; Trégouët DA; Gagnon F
    J Thromb Haemost; 2016 Oct; 14(10):1960-1970. PubMed ID: 27490645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke.
    Duering C; Kosch A; Langer C; Thedieck S; Nowak-Göttl U
    Thromb Haemost; 2004 Oct; 92(4):707-12. PubMed ID: 15467899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway.
    Deguchi H; Fernández JA; Pabinger I; Heit JA; Griffin JH
    Blood; 2001 Apr; 97(7):1907-14. PubMed ID: 11264150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis.
    Amini-Nekoo A; Futers TS; Moia M; Mannucci PM; Grant PJ; Ariëns RA
    Br J Haematol; 2001 May; 113(2):537-43. PubMed ID: 11380428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 536C-->T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis.
    Kleesiek K; Schmidt M; Götting C; Schwenz B; Lange S; Müller-Berghaus G; Brinkmann T; Prohaska W
    Thromb Haemost; 1999 Jul; 82(1):1-5. PubMed ID: 10456444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer.
    Fei X; Wang H; Yuan W; Wo M; Jiang L
    Biomed Res Int; 2017; 2017():8983763. PubMed ID: 28246607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma.
    Castoldi E; Simioni P; Tormene D; Rosing J; Hackeng TM
    J Thromb Haemost; 2010 Feb; 8(2):294-300. PubMed ID: 20002538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor.
    Khialani D; Vasan S; Cushman M; Dahm AEA; Sandset PM; Rossouw J; van Hylckama Vlieg A
    J Thromb Haemost; 2021 Jul; 19(7):1729-1737. PubMed ID: 33774921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation.
    Golino P; Ragni M; Cimmino G; Forte L
    Cardiovasc Drug Rev; 2002; 20(1):67-80. PubMed ID: 12070535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level.
    Ishikawa J; Okada H; Kato H; Takeshita S; Honda S; Kawasaki T; Suehisa E; Tsuji H; Madoiwa S; Sakata Y; Kojima T; Murata M; Ikeda Y; Kokubo Y; Okamura T; Tomoike H; Miyata T
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):22-6. PubMed ID: 20523161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation Factor Hyperfunction After Subarachnoid Hemorrhage Induces Deep Venous Thrombosis.
    Miao W; Zhao K; Deng W; Teng J
    World Neurosurg; 2018 Feb; 110():e46-e52. PubMed ID: 29196248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study.
    Winckers K; Siegerink B; Duckers C; Maurissen LF; Tans G; Castoldi E; Spronk HM; Ten Cate H; Algra A; Hackeng TM; Rosendaal FR
    J Thromb Haemost; 2011 Nov; 9(11):2243-50. PubMed ID: 21895962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.